The University of Chicago Header Logo

Connection

Richard A. Larson to Quinolines

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Quinolines.
Richard A. Larson
Connection Strength
0.178
Quinolines
  1. Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia. Haematologica. 2017 03; 102(3):519-528.
    View in: PubMed
    Score: 0.135
  2. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020 04; 34(4):966-984.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.